Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke
The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) has been associated with diabetes and cardiovascular disease; however, whether the relationship is causal is uncertain. We conducted a two-sample Mendelian randomization study to investigate the associations of PCOS with type 2 diabetes, coronary heart disease (CHD), and stroke. Association between PCOS and diabetes risk was examined in European and Asian cohorts, both sex specific and sex combined. Causal effects of PCOS on risks of CHD and stroke were evaluated in European cohorts. Stroke was analyzed as any stroke as well as four subtypes of stroke (ischemic, large artery, cardioembolic, small vessel). We found no association of genetically predicted PCOS with risk of diabetes, CHD, or stroke. This suggests that PCOS in and of itself does not increase the risk of these outcomes. Other features of PCOS (obesity, elevated testosterone, low sex hormone binding globulin) may explain the association between PCOS and cardiometabolic diseases. In light of these results, efforts to prevent cardiometabolic complications in PCOS should focus on women with high-risk features rather than all women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity, insulin resistance, and dyslipidemia are common clinical features in women with PCOS and increase the risk for cardiometabolic diseases and reproductive cancers by ≥50% [3]”
From Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review (2025) · cites this paper as [3]
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 6×
“In all cases, the MR-Egger intercepts were not different from zero, indicating absence of directional pleiotropy.”
BackgroundMethodInfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The weighted median approach can provide a consistent causal effect estimate as long as at least 50% of the information contributing to the analysis comes from valid instrumental variables (20).”
BackgroundMethodThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · cited 2×
“We used R 3.6.3 software and the R package TwoSampleMR (22) for the analyses.”
MethodInfluentialBurgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization
Bowden, J., Del Greco M, F., Minelli, C., Davey Smith, G., Sheehan, N., & Thompson, J. (2017) · Statistics in Medicine · doi:10.1002/sim.7221 · Cited by 1,887 · cited 1×
“Primary MR analyses were conducted with the inverse variance weighted (IVW) method with random effects (18).”
MethodMahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
ResultMalik, R., Chauhan, G., Traylor, M., Sargurupremraj, M., Okada, Y., Mishra, A., Rutten-Jacobs, L., Giese, A.-K., van der Laan, S. W., Gretarsdottir, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0058-3 · Cited by 1,599
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., Yengo, L., Ferreira, T., Marouli, E., Ji, Y., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy327 · Cited by 1,163
van der Harst, P., & Verweij, N. (2018) · Circulation Research · doi:10.1161/circresaha.117.312086 · Cited by 1,141 · cited 1×
“Genetic association data on CHD were acquired from the CHD GWAS meta-analysis of the UK Biobank (UKBB) with the Coronary ARtery DIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) plus the Coronary Artery Disease (C4D) Genetics (CARDIoGRAMplusC4D) consortium, which encompassed 34,541 CHD case and 261,984 co…”
MethodHartwig, F. P., Davies, N. M., Hemani, G., & Davey Smith, G. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyx028 · Cited by 860 · cited 1×
“Of the 14 SNPs, all were included to construct the genetic instrument for PCOS except SNP rs853854, because it is a palindromic SNP (A/T) with an effect allele frequency close to 50% (12).”
BackgroundChen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782 · cited 2×
“SNPs associated with PCOS in Asians were selected from two PCOS GWAS conducted in cohorts of Han Chinese ancestry (1,4).”
BackgroundMethodSex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726 · cited 1×
“Numerous epidemiologic and MR studies have associated lower SHBG with higher risk of diabetes in women and men, strongly suggesting a causal relationship (24,36,37).”
BackgroundUsing human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678 · cited 3×
“SNPs associated with PCOS in Asians were selected from two PCOS GWAS conducted in cohorts of Han Chinese ancestry (1,4).”
BackgroundMethodDay, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
Self-citationThe effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539 · cited 1×
“Several studies have documented that women with PCOS have increased BMI compared with women without PCOS (29).”
BackgroundMenstrual cycle irregularity and risk for future cardiovascular disease
Solomon, C. G., Hu, F. B., Dunaif, A., Rich-Edwards, J. E., Stampfer, M. J., Willett, W. C., Speizer, F. E., & Manson, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8471 · Cited by 528 · cited 1×
“Several prior meta-analyses (10,11,41) addressing whether PCOS was associated with increased CHD and/or stroke were heavily influenced by large cohort studies where the underlying condition was irregular menses, rather than formally diagnosed PCOS (42,43).”
BackgroundHayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478
Self-citationDay, F. R., Hinds, D. A., Tung, J. Y., Stolk, L., Styrkarsdottir, U., Saxena, R., Bjonnes, A., Broer, L., Dunger, D. B., Halldorsson, B. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9464 · Cited by 459 · cited 2×
“MR suggests that low SHBG may be a causal factor for PCOS itself (2,3).”
BackgroundIdentification of type 2 diabetes loci in 433,540 East Asian individuals
Spracklen, C. N., Horikoshi, M., Kim, Y. J., Lin, K., Bragg, F., Moon, S., Suzuki, K., Tam, C. H. T., Tabara, Y., Kwak, S.-H., et al. (2020) · Nature · doi:10.1038/s41586-020-2263-3 · Cited by 440 · cited 1×
“We obtained GWAS summary data on type 2 diabetes in Asians from the Asian Genetic Epidemiology Network (AGEN) consortium with 77,418 case and 356,122 control subjects of East Asian ancestry (15).”
MethodOsibogun, O., Ogunmoroti, O., & Michos, E. D. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.010 · Cited by 423 · cited 1×
“, increased carotid intima-media thickness, increased coronary artery calcium), whether this translates into increased CVD events is uncertain, as fewer studies have addressed the latter question (40).”
BackgroundCassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · cited 14×
“MR suggests that low SHBG may be a causal factor for PCOS itself (2,3).”
MethodInfluentialEpidemiology and Adverse Cardiovascular Risk Profile of Diagnosed Polycystic Ovary Syndrome
Lo, J. C., Feigenbaum, S. L., Yang, J., Pressman, A. R., Selby, J. V., & Go, A. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2430 · Cited by 414 · cited 1×
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
Resultde Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394 · cited 1×
“Several prior meta-analyses (10,11,41) addressing whether PCOS was associated with increased CHD and/or stroke were heavily influenced by large cohort studies where the underlying condition was irregular menses, rather than formally diagnosed PCOS (42,43).”
BackgroundKakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384 · cited 12×
“We analyzed two race groups and obtained similar results, an important feature given the prior suggestion from meta-analyses that the risk of diabetes in PCOS might be greater in Asians than in Europeans (9).”
BackgroundResultInfluentialRiaz, H., Khan, M. S., Siddiqi, T. J., Usman, M. S., Shah, N., Goyal, A., Khan, S. S., Mookadam, F., Krasuski, R. A., & Ahmed, H. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3788 · Cited by 358
Perry, J. R. B., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., Thorleifsson, G., Grallert, H., Ferrucci, L., Maggio, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp522 · Cited by 217 · cited 1×
“Numerous epidemiologic and MR studies have associated lower SHBG with higher risk of diabetes in women and men, strongly suggesting a causal relationship (24,36,37).”
BackgroundHypothalamic Amenorrhea and the Long-Term Health Consequences
Torbati, T., Dutra, E., & Shufelt, C. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603581 · Cited by 185 · cited 1×
“This is problematic because other disorders featuring irregular menses, such as hypothalamic amenorrhea, may also be associated with CVD risk (44).”
BackgroundPolycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao, L., Zhu, Z., Lou, H., Zhu, G., Huang, W., Zhang, S., & Liu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9553 · Cited by 174 · cited 2×
“Several prior meta-analyses (10,11,41) addressing whether PCOS was associated with increased CHD and/or stroke were heavily influenced by large cohort studies where the underlying condition was irregular menses, rather than formally diagnosed PCOS (42,43).”
BackgroundThe Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E. (2019) · Diabetes Care · doi:10.2337/dc18-1738 · Cited by 174 · cited 1×
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
ResultSex hormone-binding globulin and polycystic ovary syndrome
Zhu, J.-L., Chen, Z., Feng, W.-J., Long, S.-L., & Mo, Z.-C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.09.010 · Cited by 169 · cited 1×
“Low SHBG is a well-established feature of PCOS and is thought to arise from the effect of insulin resistance or hyperinsulinemia on the liver (38).”
BackgroundMorgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136
Menstrual Irregularity and Cardiovascular Mortality
Wang, E. T., Cirillo, P. M., Vittinghoff, E., Bibbins-Domingo, K., Cohn, B. A., & Cedars, M. I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1709 · Cited by 110 · cited 1×
“Several prior meta-analyses (10,11,41) addressing whether PCOS was associated with increased CHD and/or stroke were heavily influenced by large cohort studies where the underlying condition was irregular menses, rather than formally diagnosed PCOS (42,43).”
BackgroundRamezani Tehrani, F., Amiri, M., Behboudi-Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 91 · cited 3×
“To this point, some observational studies have suggested that PCOS may increase risk of diabetes or CVD in younger women but not in older women (45,46).”
BackgroundCree-Green, M., Rahat, H., Newcomer, B. R., Bergman, B. C., Brown, M. S., Coe, G. V., Newnes, L., Garcia-Reyes, Y., Bacon, S., Thurston, J. E., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00192 · Cited by 82 · cited 1×
“While obese women with PCOS consistently have greater insulin resistance than BMI-matched control subjects, some studies but not others find that this is also the case for nonobese PCOS (6,7).”
BackgroundKazemi Jaliseh, H., Ramezani Tehrani, F., Behboudi-Gandevani, S., Hosseinpanah, F., Khalili, D., Cheraghi, L., & Azizi, F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.09.004 · Cited by 80 · cited 1×
“To this point, some observational studies have suggested that PCOS may increase risk of diabetes or CVD in younger women but not in older women (45,46).”
BackgroundAssociation of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
Zhang, B., Wang, J., Shen, S., Liu, J., Sun, J., Gu, T., Ye, X., Zhu, D., & Bi, Y. (2018) · BioMed Research International · doi:10.1155/2018/6869705 · Cited by 73 · cited 1×
“Observational studies have yielded conflicting results in this regard (26,34,35).”
ResultForslund, M., Landin-Wilhelmsen, K., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoz042 · Cited by 66 · cited 1×
“Observational studies have yielded conflicting results in this regard (26,34,35).”
ResultThe cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
Meun, C., Gunning, M. N., Louwers, Y. V., Peters, H., Roos‐Hesselink, J., Roeters van Lennep, J., Rueda Ochoa, O., Appelman, Y., Lambalk, N., Boersma, E., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14117 · Cited by 65 · cited 1×
“In a study of 200 women with PCOS aged 45 years and older and 200 age-matched control subjects, the prevalence of diabetes, metabolic syndrome, dyslipidemia, and calculated 10-year CVD risk was similar (49).”
BackgroundZhou, Y., Wang, X., Jiang, Y., Ma, H., Chen, L., Lai, C., Peng, C., He, C., & Sun, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347779 · Cited by 64 · cited 2×
“Several prior meta-analyses (10,11,41) addressing whether PCOS was associated with increased CHD and/or stroke were heavily influenced by large cohort studies where the underlying condition was irregular menses, rather than formally diagnosed PCOS (42,43).”
BackgroundZhao, X., Zhong, J., Mo, Y., Chen, X., Chen, Y., & Yang, D. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.09.021 · Cited by 61 · cited 1×
“Observational studies have yielded conflicting results in this regard (26,34,35).”
ResultFamilial associations between polycystic ovarian syndrome and common diseases
Moini, A., & Eslami, B. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-009-9297-7 · Cited by 47
Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome
Boumosleh, J. M., Grundy, S. M., Phan, J., Neeland, I. J., Chang, A. Y., & Vega, G. L. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00323 · Cited by 39 · cited 1×
“While obese women with PCOS consistently have greater insulin resistance than BMI-matched control subjects, some studies but not others find that this is also the case for nonobese PCOS (6,7).”
BackgroundIs There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Carmina, E., & Lobo, R. A. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7162 · Cited by 38 · cited 1×
“Furthermore, as women with PCOS advance in age, the syndrome may improve or even regress entirely with reduction in ovarian size and androgen production (47).”
BackgroundThe association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
Valderhaug, T. G., Hertel, J. K., Nordstrand, N., Dale, P. O., Hofsø, D., & Hjelmesæth, J. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0040-5 · Cited by 35
Rasmussen, J., Selmer, C., Frøssing, S., Schou, M., Faber, J. O., Torp-Pedersen, C. T., Gislason, G., Køber, L., HOUGAARD, D. M., Cohen, A. S., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa050 · Cited by 26 · cited 1×
“A recent health care registry study of women selected to be free of comorbidities (including PCOS) found that higher testosterone and lower SHBG were associated with incident diabetes, suggesting that these relationships apply to women in general (39).”
BackgroundDoes the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age?
Azziz, R. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.09.034 · Cited by 20 · cited 1×
“Considering the potential causal role of androgens in cardiometabolic risk (24), this improvement might result in reduced risk of diabetes and CHD with aging (48).”
Background
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“However, another Mendelian randomization analysis did not find a causal role for PCOS in T2DM, coronary heart disease or stroke, suggesting that PCOS and cardiometabolic disease share common underpinnings (for example, obesity) rather than a causal relationship 91 .”
Self-citationDeconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 188
Heidarzadehpilehrood, R., Pirhoushiaran, M., Abdollahzadeh, R., Osman, M. B., Sakinah, M., Nordin, N., & Hamid, H. A. (2022) · Genes · doi:10.3390/genes13020302 · Cited by 152
“The most important risk factors for this cancer include polycystic ovary syndrome, diabetes, and obesity [104].”
Background
Metadata
- Authors
- Zhu, T., Cui, J., & Goodarzi, M. O.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Goodarzi, Mark O.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-11-06
- Volume
- 70
- Issue
- 2
- Pages
- 627-637
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W3095084496
- Cited by
- 226
- References
- 53
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 36 · 2023: 83 · 2022: 29 · 2021: 13
- FWCI
- 27.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- polycystic ovary syndrome, type 2 diabetes, coronary artery disease, stroke, cardiometabolic disease, causal inference, genetic risk prediction, sex differences, stroke subtypes, obesity, testosterone, sex hormone-binding globulin
- MeSH terms
- Adult, Coronary Disease, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk, Comorbidity, Case-Control Studies, Stroke, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.